These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Traditional use of sakau (kava) in Pohnpei: lessons for integrative medicine. Balick MJ; Lee R Altern Ther Health Med; 2002; 8(4):96-8. PubMed ID: 12126179 [No Abstract] [Full Text] [Related]
6. Kava kava in the treatment of generalized anxiety disorder, simple phobia and specific social phobia. Boerner RJ Phytother Res; 2001 Nov; 15(7):646-7. PubMed ID: 11746854 [TBL] [Abstract][Full Text] [Related]
7. Kava: a comprehensive review of efficacy, safety, and psychopharmacology. Sarris J; LaPorte E; Schweitzer I Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders. Witte S; Loew D; Gaus W Phytother Res; 2005 Mar; 19(3):183-8. PubMed ID: 15934028 [TBL] [Abstract][Full Text] [Related]
12. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial. Volz HP; Kieser M Pharmacopsychiatry; 1997 Jan; 30(1):1-5. PubMed ID: 9065962 [TBL] [Abstract][Full Text] [Related]
13. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward? Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850 [TBL] [Abstract][Full Text] [Related]
14. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869 [TBL] [Abstract][Full Text] [Related]
15. Kava treatment in patients with anxiety. Geier FP; Konstantinowicz T Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364 [TBL] [Abstract][Full Text] [Related]
16. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum. Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines. Malsch U; Kieser M Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083 [TBL] [Abstract][Full Text] [Related]
18. Over-the-counter psychotropics: a review of melatonin, St John's wort, valerian, and kava-kava. Heiligenstein E; Guenther G J Am Coll Health; 1998 May; 46(6):271-6. PubMed ID: 9609974 [TBL] [Abstract][Full Text] [Related]
19. The health and social effects of drinking water-based infusions of kava: a review of the evidence. Rychetnik L; Madronio CM Drug Alcohol Rev; 2011 Jan; 30(1):74-83. PubMed ID: 21219501 [TBL] [Abstract][Full Text] [Related]
20. [Piper methysticum (kava) under discussion: observations on quality, effectiveness and safety]. Schmidt M; Nahrstedt A; Lüpke NP Wien Med Wochenschr; 2002; 152(15-16):382-8. PubMed ID: 12244883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]